254 related articles for article (PubMed ID: 10441556)
21. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
Chu TH; Martinez I; Sheay WC; Dornburg R
Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
[TBL] [Abstract][Full Text] [Related]
22. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
24. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
[TBL] [Abstract][Full Text] [Related]
26. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
27. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
Lindemann D; Bock M; Schweizer M; Rethwilm A
J Virol; 1997 Jun; 71(6):4815-20. PubMed ID: 9151877
[TBL] [Abstract][Full Text] [Related]
28. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
[TBL] [Abstract][Full Text] [Related]
30. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
Hatziioannou T; Russell SJ; Cosset FL
Virology; 2000 Feb; 267(1):49-57. PubMed ID: 10648182
[TBL] [Abstract][Full Text] [Related]
31. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
32. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of wild-type HIV-1 virus production by a matrix deficient Gag mutant.
Lee PP; Linial ML
Virology; 1995 Apr; 208(2):808-11. PubMed ID: 7747455
[TBL] [Abstract][Full Text] [Related]
34. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
Christodoulopoulos I; Cannon PM
J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
[TBL] [Abstract][Full Text] [Related]
35. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner.
Henriksson P; Bosch V
Virology; 1998 Nov; 251(1):16-21. PubMed ID: 9813198
[TBL] [Abstract][Full Text] [Related]
37. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
Broder CC; Dimitrov DS; Blumenthal R; Berger EA
Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
[TBL] [Abstract][Full Text] [Related]
38. Membrane fusion between retroviral particles: host-range extension and vaccine prospects.
Sparacio S; Zeilfelder U; Pfeiffer T; Henzler T; Bosch V
Virology; 2000 Jun; 271(2):248-52. PubMed ID: 10860878
[TBL] [Abstract][Full Text] [Related]
39. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
Herrera C; Klasse PJ; Michael E; Kake S; Barnes K; Kibler CW; Campbell-Gardener L; Si Z; Sodroski J; Moore JP; Beddows S
Virology; 2005 Jul; 338(1):154-72. PubMed ID: 15932765
[TBL] [Abstract][Full Text] [Related]
40. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
